GondolaBio
Develops clinical-stage therapeutics for rare genetic diseases.
biotechpharmaceuticals
Company facts
- Founded
- 2024
- Employees
- 45
- Headquarters
- United States
- Type
- Private
- Funding
- Corporate Round · $300M · 2024
- Subsidiaries
- Portal Therapeutics
Open positions
3 jobs
48 views last week
Associate Director/Director, Asset Acquisition
New RemoteNorth America
United States
Palo Alto, CA, Boston, MAAbout GondolaBio GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally…
Business Development